EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Regenerative Approaches in Vulvar Lichen Sclerosus: A Systematic Review

Katarzyna Beutler iD, Alina Jankowska-Konsur iD, Danuta Nowicka iD

International Journal of Molecular Sciences · 10.09.2025 · 26 (18) · 8808

DOI: 10.3390/ijms26188808 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.09.2025. Verfasst von Katarzyna Beutler und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-368 Wroclaw, Poland. Hauptthemen laut MEDLINE: Vulvar Lichen Sclerosus, Mesenchymal Stem Cell Transplantation, Regenerative Medicine, Regeneration. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University, Wrocław Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vulvar lichen sclerosus (VLS) involves chronic inflammation, immune dysregulation, and abnormal extracellular matrix remodeling, involving extracellular matrix protein 1 (ECM1) and non-coding RNAs, particularly miR-155. Platelet-rich plasma (PRP) and adipose-derived mesenchymal stem cells (ADSCs) offer regenerative potential through the release of growth factors and cytokines that promote angiogenesis, fibroblast proliferation, collagen synthesis, and tissue repair, which could potentially compensate for the disordered matrix in VLS. This systematic review aimed to evaluate the current evidence on the efficacy and safety of PRP, ADSCs, and active substances administered through mesotherapy to adult women with VLS. A search of the PubMed, Scopus, and Web of Science databases identified 251 records, of which 13 studies met the inclusion criteria (RCTs and cohort studies involving women aged ≥ 18 years who were treated with PRP, ADSCs, or mesotherapy). The reviewed studies suggest that these therapies may improve clinical symptoms, quality of life, sexual function, and tissue quality. However, their application may be constrained by procedural invasiveness and potential immunologic risks. Moreover, the current evidence base is limited by small sample sizes, a lack of control groups, and short follow-up periods. Larger, well-designed randomized controlled trials with long-term follow-up are needed to confirm their therapeutic value and establish clear clinical guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vulvar Lichen SclerosusMesenchymal Stem Cell TransplantationRegenerative MedicineRegenerationHumansFemalePlatelet-Rich PlasmaMesenchymal Stem Cells

Stichwörter der Autor:innen

alternative treatmentemerging therapymesotherapyvulvar lichen sclerosus

Autor:innen und Institutionen

  • University Centre of General Dermatology and Oncodermatology, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Division of Aesthetic Dermatology and Regenerative Medicine of the Skin, Wroclaw Medical University, 50-368 Wroclaw, Poland.

ORCID-Profile: Katarzyna Beutler, Alina Jankowska-Konsur, Danuta Nowicka

Förderung

  • Wroclaw Medical University
  • Wrocław Medical University

Zitieren

APA

Beutler, K., Jankowska-Konsur, A., & Nowicka, D. (2025). Regenerative Approaches in Vulvar Lichen Sclerosus: A Systematic Review. International Journal of Molecular Sciences, 26(18), 8808. https://doi.org/10.3390/ijms26188808

Vancouver

Beutler K, Jankowska-Konsur A, Nowicka D. Regenerative Approaches in Vulvar Lichen Sclerosus: A Systematic Review. International Journal of Molecular Sciences. 2025;26(18):8808. doi:10.3390/ijms26188808

BibTeX
@article{Beutler2025,
  author = {Beutler, Katarzyna and Jankowska-Konsur, Alina and Nowicka, Danuta},
  title = {Regenerative Approaches in Vulvar Lichen Sclerosus: A Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {18},
  pages = {8808},
  doi = {10.3390/ijms26188808}
}
Kostenlos starten →